Welcome to our dedicated page for Nugene Intl news (Ticker: NUGN), a resource for investors and traders seeking the latest updates and insights on Nugene Intl stock.
Livento Group Inc. reports company updates around its acquisition-and-development strategy in film, content, technology, AI/robotics and logistics. Recurring announcements cover BOXO Productions film projects and releases, the Elisee semi-automated portfolio management tool, Global Dot Logistics, and efforts to build or finance operating holdings. News also includes OTC-market corporate actions, share-structure initiatives, equity financing agreements and periodic operating-result updates tied to its portfolio businesses.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
NuGene International, Inc./Livento Group, Inc. (OTC Pink: NUGN) has initiated the Public Offering process for its logistics project, EuroDot. With final stages underway, legal and financial documents are being prepared for a Reg A listing on OTC Markets. Livento Group aims to attract U.S. investors for future acquisitions, targeting revenues of $50 million by 2024 from two profitable acquisition targets, one with $14 million and another with $20 million in revenues, respectively. Initial share price for investors is set at $0.5. A detailed timeline and further financial disclosures are expected in the coming weeks.
NuGene International, Inc./Livento Group (OTC Pink: NUGN) has signed a binding Letter of Intent to acquire a Software Engineering Company specializing in AI and Robotics. The deal is expected to finalize in January 2023 and aims to enhance Livento's business portfolio. The target company is projected to generate $400,000 in revenue for 2023 with a 50% YOY increase. Additionally, Livento plans to leverage available EU grants of $750,000 to support the acquisition's growth. The acquisition is anticipated to provide positive cash flow from day one.